Levothyroxine compositions having unique triiodothyronine Tmax properties
First Claim
Patent Images
1. A stabilized pharmaceutical composition in solid dosage form comprised of a levothyroxine salt and having less than about 10% total impurities as determined by a standard USP impurity test.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
-
Citations
15 Claims
- 1. A stabilized pharmaceutical composition in solid dosage form comprised of a levothyroxine salt and having less than about 10% total impurities as determined by a standard USP impurity test.
Specification